Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Profiles will have a brief outage at 6pm this Friday, 5/30/2025, for system upgrade.

Thomas J Hwang, M.D.

Concepts (215)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Drug Approval3320248186.450 Why?
United States Food and Drug Administration32202416722.990 Why?
Device Approval920231642.870 Why?
Drug Costs13202311932.770 Why?
Prescription Drugs720236342.300 Why?
Legislation, Drug620232172.180 Why?
Medicare Part D520223552.170 Why?
European Union920241572.060 Why?
Rare Diseases520196351.790 Why?
Drug Information Services32020511.750 Why?
Clinical Trials as Topic15202480411.660 Why?
Drugs, Investigational520192111.580 Why?
Product Surveillance, Postmarketing520234641.520 Why?
Drug Discovery7201710641.350 Why?
Drug and Narcotic Control220221441.250 Why?
Antineoplastic Agents152024136481.250 Why?
Neoplasms182024223401.230 Why?
Government Regulation320195251.160 Why?
Medicare Part B220191151.060 Why?
Orphan Drug Production42018480.970 Why?
Pediatrics6202036060.940 Why?
Consumer Product Safety220161210.920 Why?
Policy Making420165460.910 Why?
United States542024729030.890 Why?
Biomedical Research6201934580.850 Why?
Health Care Reform2202212590.850 Why?
BCG Vaccine220233800.820 Why?
Medicaid4202328330.810 Why?
Drugs, Essential12022710.780 Why?
Pharmaceutical Preparations9202310840.730 Why?
Drug Industry820237910.720 Why?
Federal Government120222650.700 Why?
Europe11202334230.680 Why?
Health Policy7202026980.680 Why?
Prescription Fees220211530.650 Why?
Inflation, Economic12019290.650 Why?
Cost Sharing220224090.640 Why?
Drug Evaluation120206410.640 Why?
Technology Assessment, Biomedical120223120.640 Why?
Commerce220156110.630 Why?
Health Expenditures3202223870.620 Why?
Cultural Diversity120223700.620 Why?
Urologic Neoplasms120223100.600 Why?
Clinical Trials, Phase III as Topic320188780.600 Why?
Artificial Intelligence2202426590.570 Why?
Tuberculosis, Multidrug-Resistant320149420.560 Why?
Medical Device Recalls12016150.530 Why?
Anti-Bacterial Agents4201674780.530 Why?
World Health Organization1202213280.520 Why?
Medicine120249420.510 Why?
Costs and Cost Analysis4202316680.490 Why?
State Health Plans120172200.490 Why?
Decision Support Systems, Clinical1202411750.480 Why?
Surgical Equipment12015580.480 Why?
Health Planning Technical Assistance1201450.480 Why?
Public-Private Sector Partnerships120161230.470 Why?
Insurance, Pharmaceutical Services120173470.470 Why?
Small Business1201490.470 Why?
Program Development2202012950.460 Why?
Visual Prosthesis12015490.450 Why?
Leprostatic Agents12014140.450 Why?
Humans8120247659680.450 Why?
Clofazimine12014390.440 Why?
Equipment and Supplies120162730.430 Why?
Urinary Bladder Neoplasms2202321760.420 Why?
Extensively Drug-Resistant Tuberculosis12014850.420 Why?
Information Seeking Behavior120141160.420 Why?
Research Design3201962090.410 Why?
Publishing220188350.410 Why?
Reimbursement Mechanisms220166720.410 Why?
Oxazolidinones12013990.410 Why?
Motivation1202220180.400 Why?
Cycloserine120131180.400 Why?
Negotiating120141520.400 Why?
Information Dissemination1202011420.390 Why?
Fluoroquinolones120143070.380 Why?
Investments120131480.380 Why?
Isoxazoles120132340.380 Why?
United States Department of Veterans Affairs120169340.370 Why?
Drug Labeling320202500.370 Why?
Drug Resistance, Bacterial2201610690.360 Why?
Cardiovascular Agents120178510.360 Why?
Politics220168220.360 Why?
Treatment Failure1201626520.350 Why?
Escherichia coli Infections120145190.330 Why?
Reimbursement, Incentive120155410.330 Why?
Drug Utilization1201511870.320 Why?
Drug Resistance, Multiple, Bacterial120145920.320 Why?
Contact Tracing120112740.320 Why?
Migraine Disorders1202217320.320 Why?
Retinal Diseases120157090.310 Why?
Ophthalmology120155610.300 Why?
Patient Selection1202042550.300 Why?
National Health Programs120114430.300 Why?
Molecular Targeted Therapy4202428220.300 Why?
Marketing220222250.300 Why?
Prostheses and Implants1201512730.300 Why?
Switzerland320233220.280 Why?
Urinary Tract Infections120148050.280 Why?
Vaccines120168410.280 Why?
Guidelines as Topic1201413940.280 Why?
Child142023805640.270 Why?
Bacterial Infections1201513870.270 Why?
Anti-Infective Agents120149860.260 Why?
Antitubercular Agents1201413840.260 Why?
Outpatients1201415950.250 Why?
Communicable Diseases120148740.250 Why?
Software1201944620.250 Why?
Canada2202221190.240 Why?
Opioid-Related Disorders1201921780.230 Why?
Therapies, Investigational220161100.230 Why?
Pain1201950770.230 Why?
Hypoglycemic Agents1201731100.230 Why?
Drugs, Generic220224560.230 Why?
Health Services Accessibility4201855080.220 Why?
Analgesics, Opioid1201938350.210 Why?
Ambulatory Care1201427780.200 Why?
Coronavirus Infections1202031000.200 Why?
Pneumonia, Viral1202032230.200 Why?
Government Agencies220191610.190 Why?
Escherichia coli1201442140.190 Why?
Cohort Studies62023416490.190 Why?
Cardiovascular Diseases22017156520.180 Why?
Quality of Life32020134620.180 Why?
Patient-Centered Care2202314580.180 Why?
Medical Oncology3202423390.170 Why?
Central Nervous System Diseases220155180.170 Why?
Television120234090.170 Why?
Prescriptions120223880.170 Why?
Tuberculosis1201120120.160 Why?
Biological Factors120191550.150 Why?
Patents as Topic120191110.150 Why?
Medicare2202168230.150 Why?
Databases, Factual4201880670.150 Why?
Japan1202214150.150 Why?
Retrospective Studies72023815140.140 Why?
Tropical Medicine12017520.140 Why?
Early Termination of Clinical Trials12016700.130 Why?
Clinical Trials, Phase I as Topic220173300.130 Why?
Cost-Benefit Analysis3202155260.130 Why?
Practice Guidelines as Topic3202474250.130 Why?
Time Factors52019400650.120 Why?
United States Government Agencies12015260.120 Why?
Neoplasm Invasiveness1202336020.120 Why?
Conjunctivitis, Bacterial12015220.120 Why?
Central Nervous System Agents12015720.120 Why?
New York120178800.120 Why?
Public Policy120195510.120 Why?
Encyclopedias as Topic12014190.120 Why?
Area Under Curve1201816380.120 Why?
Compassionate Use Trials12014490.110 Why?
Capital Financing12014580.110 Why?
Small Molecule Libraries120197410.110 Why?
Lenses, Intraocular120151410.110 Why?
Equipment Safety120142500.100 Why?
Diabetes Mellitus, Type 212017122400.100 Why?
Cross-Sectional Studies52024263180.100 Why?
Public Opinion120164820.100 Why?
Antibiotics, Antitubercular120131000.100 Why?
Infant32020363860.100 Why?
California1201614360.100 Why?
Statistics, Nonparametric2201828440.100 Why?
Age Factors22020183800.100 Why?
Safety1201611570.100 Why?
Child, Preschool32020425000.090 Why?
Randomized Controlled Trials as Topic32019103830.090 Why?
Clinical Trials, Phase II as Topic120146390.090 Why?
Diffusion of Innovation120167210.090 Why?
Adolescent52023888350.090 Why?
Models, Economic120137160.080 Why?
Germany220228820.080 Why?
Biological Products120189420.080 Why?
Regression Analysis1201863220.080 Why?
Disease-Free Survival1201868320.070 Why?
Insurance Coverage1201919440.070 Why?
Needs Assessment1201411380.070 Why?
Macular Degeneration1201510140.070 Why?
Immunotherapy1202347520.070 Why?
Infant, Newborn22019263460.070 Why?
Microbial Sensitivity Tests1201419710.070 Why?
Policy220215110.070 Why?
Periodicals as Topic1201614620.060 Why?
Aged420221711170.060 Why?
Quality Improvement1202038530.060 Why?
Neoplasm Recurrence, Local1202393730.060 Why?
Drug Prescriptions1201416620.060 Why?
Proportional Hazards Models12019125090.060 Why?
Decision Making2201539650.050 Why?
Inpatients1201525640.050 Why?
Internet1201431060.050 Why?
Treatment Outcome32019651880.050 Why?
Pandemics1202087030.040 Why?
Systems Analysis120201680.040 Why?
Developing Countries1201129110.040 Why?
France120204950.040 Why?
England120205330.040 Why?
Neglected Diseases12018670.040 Why?
Administration, Intravesical12017880.030 Why?
Follow-Up Studies12019391930.030 Why?
Computer Graphics120193440.030 Why?
Endpoint Determination120195910.030 Why?
Pharmacology, Clinical12015230.030 Why?
Male520193636980.030 Why?
Female520193961120.030 Why?
Ophthalmic Solutions120153120.030 Why?
Financing, Government120174730.030 Why?
Mental Disorders1201368530.030 Why?
Algorithms12013140710.030 Why?
Genome, Human1202444480.020 Why?
Patient Participation1201914550.020 Why?
Genomics1202459290.020 Why?
Young Adult12014598890.020 Why?
Health Care Costs1201732420.010 Why?
Middle Aged120142230090.010 Why?
Adult120142230440.010 Why?
Hwang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (215)
Explore
_
Co-Authors (24)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.